Pregled bibliografske jedinice broj: 188750
Enzyme replacement therapy for MPS I - follow up of two patients
Enzyme replacement therapy for MPS I - follow up of two patients // Book of Abstracts of the European Human Genetics Conference ; u: European Journal of Human Genetics. Supplement 12 (2004) (S1)
München, Njemačka, 2004. str. 349-349 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 188750 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Enzyme replacement therapy for MPS I - follow up of two patients
Autori
Barišić, Ingeborg ; Huzjak, Nevenka ; Tokić, Višnja ; Fumić, Ksenija ; Antičević, Darko ; Mrsić, Mirando
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Book of Abstracts of the European Human Genetics Conference ; u: European Journal of Human Genetics. Supplement 12 (2004) (S1)
/ - , 2004, 349-349
Skup
European Human Genetics Conference
Mjesto i datum
München, Njemačka, 12.06.2004. - 15.06.2004
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
enzyme replacement therapy; MPS I; Morbus Hurler
Sažetak
We present the one-year follow up results of two MPS I patients on enzyme replacement therapy with rh alpha-L-iduronidase (Aldurazyme). In the first patient, a 9 year old boy, we observed significant progress in mobility and general physical condition. We also noticed improvement of hearing and visual acuity, and reduction in spleen and liver size. The symptoms and signs of sleep-apnea syndrome disappeared. Cardiac function (NYHA II) remained stable. The leukocyte alpha-L-iduronidase activity reached therapeutic values. The second patient, an 8 year old girl, demonstrated similar improvements in the first six months of therapy: the amelioration of the respiratory function, hearing, and visual acuity, and a reduction in spleen and liver size. The sleep-apnea episodes disappeared. However, in the last six months we have not registered further improvements, and the clinical parameters remained stationary. We conclude that long term clinical and biochemical follow up is necessary to evaluate the individual response to the enzyme replacement therapy of MPS I patients.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
0072165
Ustanove:
Klinika za dječje bolesti Medicinskog fakulteta
Profili:
Darko Antičević
(autor)
Višnja Tokić
(autor)
Mirando Mrsić
(autor)
Ksenija Fumić
(autor)
Ingeborg Barišić
(autor)
Nevenka Huzjak
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE